Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00258193
Status:
COMPLETED
Last Update Posted:
2006-10-20
First Post:
2005-11-22
Brief Title:
Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
Sponsor:
Ironwood Pharmaceuticals Inc
Organization:
Ironwood Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Irritable Bowel Syndrome |
Keywords:
| Name | View |
|---|---|
| linaclotide acetate | View |
| C-IBS | View |
| IBS-C | View |
| Constipation-predominant Irritable Bowel Syndrome | View |
| Constipation Predominant Irritable Bowel Syndrome | View |
| Irritable Bowel Syndrome | View |
| IBS | View |
| Transit | View |
| Scintigraphy | View |
| Gastroenterology | View |
| Gastrointestinal | View |
| GC | View |
| MD-1100 Acetate | View |
| MD-1100 | View |
| linaclotide | View |